Tech Company Financing Transactions
Torus Biosystems Funding Round
Torus Biosystems, based in Cambridge, secured $25 million in funding from Northpond Ventures and private investors.
Transaction Overview
Company Name
Announced On
5/27/2021
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
Northpond Ventures (Lead Investor) (Adam Wieschhaus)
private investors (David Walt)
Proceeds Purpose
Funding proceeds will be used to accelerate commercialization of a first-in-class syndromic testing solution designed for point-of-care use in ambulatory care settings.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
125 Cambridgepark Dr.
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Undisclosed
Website
Email Address
Overview
Torus is a recent spinout from the Harvard Wyss Institute for Biologically Inspired Engineering. We are developing the next-generation of rapid, near-patient, infectious disease diagnostics based on the integration of novel technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shawn Marcell
Chief Financial Officer
Benjamin Linden
VP - Bus. Development
Jackie Lemaitre
VP - Bus. Development
Andre Ruzycky
VP - Human Resources
Brian Thomson
VP - R & D
Brian Turczyk
VP - Regulatory Affairs
Gary Riordan
Browse more venture capital transactions:
Prev: 5/27/2021: Hello Heart venture capital transaction
Next: 5/27/2021: Topia venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs